This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


3ans

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "3ans" [edit=sysop:move=sysop])
Current revision (15:50, 4 October 2023) (edit) (undo)
 
(6 intermediate revisions not shown.)
Line 1: Line 1:
-
[[Image:3ans.jpg|left|200px]]
 
-
<!--
+
==Human soluble epoxide hydrolase in complex with a synthetic inhibitor==
-
The line below this paragraph, containing "STRUCTURE_3ans", creates the "Structure Box" on the page.
+
<StructureSection load='3ans' size='340' side='right'caption='[[3ans]], [[Resolution|resolution]] 1.98&Aring;' scene=''>
-
You may change the PDB parameter (which sets the PDB file loaded into the applet)
+
== Structural highlights ==
-
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
+
<table><tr><td colspan='2'>[[3ans]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ANS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3ANS FirstGlance]. <br>
-
or leave the SCENE parameter empty for the default display.
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.98&#8491;</td></tr>
-
-->
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=S38:4-CYANO-N-[(1S,2R)-2-PHENYLCYCLOPROPYL]BENZAMIDE'>S38</scene></td></tr>
-
{{STRUCTURE_3ans| PDB=3ans | SCENE= }}
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ans FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ans OCA], [https://pdbe.org/3ans PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ans RCSB], [https://www.ebi.ac.uk/pdbsum/3ans PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ans ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/HYES_HUMAN HYES_HUMAN] Bifunctional enzyme. The C-terminal domain has epoxide hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and arene oxides. Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides. Also determines steady-state levels of physiological mediators. The N-terminal domain has lipid phosphatase activity, with the highest activity towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid, followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-phosphonooxy-octadec-9Z-enoic acid, 12-phosphonooxy-octadec-9E-enoic acid, and p-nitrophenyl phospate.<ref>PMID:12574508</ref> <ref>PMID:12574510</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Ligand efficiency is frequently used to evaluate fragment compounds in fragment-based drug discovery. We applied ligand efficiency indices in a conventional virtual screening-initiated lead generation study of soluble epoxide hydrolase inhibitors. From a considerable number of screening hits, we carefully selected a compound exhibiting relatively weak inhibitory activity but high ligand efficiency. This ligand efficiency-guided selection could reveal compounds possessing preferable lead-like characteristics in terms of molecular size and lipophilicity. The following hit-to-lead medicinal chemistry campaign successfully led to a more potent, ADMET-clean, lead-like compound preserving high ligand efficiency. Retrospective analyses, including consideration of the more recently proposed indices of ligand efficiency, shed light on the validity of our hit triage and hit-to-lead studies. The present work proposes a practical methodology for lead generation using the concept of ligand efficiency.
-
===Human soluble epoxide hydrolase in complex with a synthetic inhibitor===
+
A Practical Use of Ligand Efficiency Indices Out of the Fragment-Based Approach: Ligand Efficiency-Guided Lead Identification of Soluble Epoxide Hydrolase Inhibitors.,Tanaka D, Tsuda Y, Shiyama T, Nishimura T, Chiyo N, Tominaga Y, Sawada N, Mimoto T, Kusunose N J Med Chem. 2010 Dec 30. PMID:21192659<ref>PMID:21192659</ref>
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 3ans" style="background-color:#fffaf0;"></div>
-
<!--
+
==See Also==
-
The line below this paragraph, {{ABSTRACT_PUBMED_21192659}}, adds the Publication Abstract to the page
+
*[[Epoxide hydrolase 3D structures|Epoxide hydrolase 3D structures]]
-
(as it appears on PubMed at http://www.pubmed.gov), where 21192659 is the PubMed ID number.
+
== References ==
-
-->
+
<references/>
-
{{ABSTRACT_PUBMED_21192659}}
+
__TOC__
-
 
+
</StructureSection>
-
==About this Structure==
+
-
[[3ans]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ANS OCA].
+
-
 
+
-
==Reference==
+
-
<ref group="xtra">PMID:21192659</ref><references group="xtra"/>
+
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
-
[[Category: Soluble epoxide hydrolase]]
+
[[Category: Large Structures]]
-
[[Category: Chiyo, N.]]
+
[[Category: Chiyo N]]
-
[[Category: Hourai, S.]]
+
[[Category: Hourai S]]
-
[[Category: Ishii, T.]]
+
[[Category: Ishii T]]
-
[[Category: Yanagi, K.]]
+
[[Category: Yanagi K]]

Current revision

Human soluble epoxide hydrolase in complex with a synthetic inhibitor

PDB ID 3ans

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3ans"
Personal tools